350 related articles for article (PubMed ID: 22336782)
1. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Bhatt J
Cochrane Database Syst Rev; 2012 Feb; (2):CD002009. PubMed ID: 22336782
[TBL] [Abstract][Full Text] [Related]
2. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Bhatt J; Nevitt SJ
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD002009. PubMed ID: 28349527
[TBL] [Abstract][Full Text] [Related]
3. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Bhatt J
Cochrane Database Syst Rev; 2014 Feb; (2):CD002009. PubMed ID: 24497229
[TBL] [Abstract][Full Text] [Related]
4. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Bhatt J
Cochrane Database Syst Rev; 2010 Jan; (1):CD002009. PubMed ID: 20091528
[TBL] [Abstract][Full Text] [Related]
5. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Bhatt J; Jahnke N; Smyth AR
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD002009. PubMed ID: 31483853
[TBL] [Abstract][Full Text] [Related]
6. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Tan KH
Cochrane Database Syst Rev; 2006 Jul; (3):CD002009. PubMed ID: 16855982
[TBL] [Abstract][Full Text] [Related]
7. Once daily versus multiple daily dosing with intravenous aminoglycosides for cystic fibrosis.
Tan K; Bunn H
Cochrane Database Syst Rev; 2000; (4):CD002009. PubMed ID: 11034740
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smyth AR
Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smyth AR
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004197. PubMed ID: 28440853
[TBL] [Abstract][Full Text] [Related]
10. Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.
Elphick HE; Scott A
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD002007. PubMed ID: 27907224
[TBL] [Abstract][Full Text] [Related]
11. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Smith S; Rowbotham NJ; Charbek E
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD008319. PubMed ID: 30376155
[TBL] [Abstract][Full Text] [Related]
12. Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.
Holland P; Jahnke N
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD002007. PubMed ID: 34159577
[TBL] [Abstract][Full Text] [Related]
13. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Ryan G; Jahnke N; Remmington T
Cochrane Database Syst Rev; 2012 Dec; 12():CD008319. PubMed ID: 23235659
[TBL] [Abstract][Full Text] [Related]
14. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD006961. PubMed ID: 28628280
[TBL] [Abstract][Full Text] [Related]
15. Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.
Palser S; Smith S; Nash EF; Agarwal A; Smyth AR
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012300. PubMed ID: 31845758
[TBL] [Abstract][Full Text] [Related]
16. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis.
Elphick HE; Jahnke N
Cochrane Database Syst Rev; 2014 Apr; (4):CD002007. PubMed ID: 24788768
[TBL] [Abstract][Full Text] [Related]
17. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
Smith S; Ratjen F; Remmington T; Waters V
Cochrane Database Syst Rev; 2020 May; 5(5):CD006961. PubMed ID: 32412092
[TBL] [Abstract][Full Text] [Related]
18. Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial.
Smyth A; Tan KH; Hyman-Taylor P; Mulheran M; Lewis S; Stableforth D; Prof Knox A;
Lancet; 2005 Feb 12-18; 365(9459):573-8. PubMed ID: 15708100
[TBL] [Abstract][Full Text] [Related]
19. Oral anti-pseudomonal antibiotics for cystic fibrosis.
Remmington T; Jahnke N; Harkensee C
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD005405. PubMed ID: 27412131
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smyth AR
Cochrane Database Syst Rev; 2009 Oct; (4):CD004197. PubMed ID: 19821321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
